Skip to main content

Zomedica Corp.

ZOMDF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001684144

No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Zomedica Corp. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of ZOMDF: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders11298−14
Shares114.0M94.7M−19.3M (−16.9%)
Value$38.3M$20.8M−$17.5M (−45.6%)

New holders (13)

Institutions that held Zomedica Corp. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to ZOMDF in Q2 2022
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC2,507,500$552.0K0.00%
Qube Research & Technologies Ltd496,788$109.0K0.00%
ExodusPoint Capital Management, LP171,703$38.0K0.00%
Rhumbline Advisers69,911$15.0K0.00%
Ergoteles LLC24,098$5.00K0.00%
Arete Wealth Advisors, LLC23,778$5.00K0.00%
JustInvest LLC21,377$5.00K0.00%
B. Riley Wealth Management, Inc.10,000$2.00K0.00%
International Assets Investment Management, LLC10,900$2.00K0.00%
Harbour Investments, Inc.140$00.00%
EverSource Wealth Advisors, LLC300$00.00%
Rockefeller Capital Management L.P.160$00.00%
Evoke Wealth, LLC33$00.00%

Sold out (27)

Institutions that held Zomedica Corp. at the end of Q1 2022 and filed for Q2 2022 without it.